Immunicum AB (publ) meddelar att abstrakten inför ASCO-SITC Clinical Immuno-Oncology Symposium publicerats

NEXT STORY
Athenex CEO Informs Shareholders of Unrelated Matter Regarding Past Board Membership at Porton Pharma
PREV STORY
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Insights on the Orphan Drugs Global Market to 2026 – by Drug Type, Disease Type, Phase, Top Selling Drugs, Distribution Channel and Region

author_avatar
NASDAQ Market News

CEPI vergibt Vertrag im Wert von bis zu 36 Mio. US-Dollar zur Entwicklung eines Impfstoffs gegen das Lassa-Virus an Profectus BioSciences und Emergent BioSolutions

OSLO, Norwegen, BALTIMORE und GAITHERSBURG, Maryland, USA, Aug. 16, 2018 (GLOBE NEWSWIRE) -- CEPI ...

author_avatar
NASDAQ Market News

VBL Therapeutics to Present at the H.C. Wainwright 6th Annual Israel Conference

author_avatar
NASDAQ Market News